Four-Year Outcomes by Donor Type from the Long-Term Extension of the Belatacept BENEFIT and BENEFIT-EXT Studies

被引:0
|
作者
Durrbach, A. [1 ]
Medina Pestana, J. [2 ]
Becker, T. [3 ]
Grinyo, J. [4 ]
Lang, P. [5 ]
Garcia, V. D. [6 ]
Agarwal, M. [7 ]
Duan, T. [7 ]
Florman, S. [8 ]
机构
[1] Hop Kremlin Bicetre, Paris, France
[2] Hosp Rim & Hipertensao, Sao Paulo, Brazil
[3] Hannover Med Sch, Hannover, Germany
[4] Univ Hosp Bellvitge, Barcelona, Spain
[5] Hop Henri Mondor, Creteil, France
[6] Hosp Dom Vicente Scherer, Porto Alegre, RS, Brazil
[7] Bristol Myers Squibb, Princeton, NJ USA
[8] Mt Sinai Med Ctr, New York, NY 10029 USA
关键词
D O I
10.1097/00007890-201211271-01950
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
1312
引用
收藏
页码:987 / 987
页数:1
相关论文
共 50 条
  • [1] FOUR-YEAR OUTCOMES BY DONOR TYPE FROM THE LONG-TERM EXTENSION OF THE BELATACEPT BENEFIT AND BENEFIT-EXT STUDIES
    Durrbach, A.
    Medina Pestana, J.
    Becker, T.
    Grinyo, J.
    Lang, P.
    Garcia, V. D.
    Duan, T.
    Florman, S.
    TRANSPLANT INTERNATIONAL, 2012, 25 : 50 - 50
  • [2] Four-Year Outcomes by Donor Type from the Long-Term Extension of the Belatacept BENEFIT and BENEFIT-EXT Studies.
    Durrbach, A.
    Florman, S.
    Zhang, R.
    Becker, T.
    Grinyo, J.
    Lang, P.
    Garcia, V. D.
    Duan, T.
    Pupim, L.
    Medina Pestana, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 407 - 407
  • [3] 5-YEAR OUTCOMES BY DONOR TYPE FROM THE LONG-TERM EXTENSION OF THE BELATACEPT BENEFIT-EXT STUDY
    Muehlbacher, Ferdinand
    Florman, Sander
    Zhang, Rubin
    Lang, Philippe
    Lehner, Frank
    Massari, Pablo
    Garcia, Valter D.
    Pupim, Lara
    Durrbach, Antoine
    TRANSPLANT INTERNATIONAL, 2013, 26 : 92 - 92
  • [4] Five-Year Outcomes by Donor Type from the Long-Term Extension of the Belatacept BENEFIT-EXT Study
    Durrbach, A.
    Florman, S.
    Zhang, R.
    Lang, P.
    Lehner, F.
    Massari, P.
    Garcia, V.
    Pupim, L.
    Muehlbacher, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 311 - 311
  • [5] Four-Year Outcomes in Black/African American Kidney Transplant Recipients from the Long-Term Extension of the Belatacept BENEFIT and BENEFIT-EXT Studies.
    Florman, S.
    Rice, K.
    Chan, L.
    Steinberg, S.
    Pearson, T.
    Duan, T.
    Argawal, M.
    Vincenti, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 404 - 404
  • [6] 4-Year Results from the Long-Term Extension of the Belatacept BENEFIT-EXT Study
    Florman, S.
    Durrbach, A.
    Grinyo, J.
    Pestana, J. O. M.
    Rial, M. d. C.
    Vitko, S.
    Lin, C. -S.
    Harler, M. B.
    Rostaing, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 82 - 82
  • [7] Long-Term Extension of the Belatacept BENEFIT-EXT Study: Results at Month 48
    Grinyo, J.
    Florman, S.
    Medina Pestana, J. O.
    del Carmen Rial, M.
    Muehlbacher, F.
    Durrbach, A.
    Vincenti, F.
    Harler, M. B.
    Duan, T.
    Rostaing, L.
    TRANSPLANTATION, 2012, 94 (10) : 974 - 974
  • [8] LONG-TERM EXTENSION OF THE BELATACEPT BENEFIT-EXT STUDY: RESULTS AT MONTH 48
    Grinyo, J.
    Florman, S.
    Medina, J.
    Rial, M. Del C.
    Muhlbacher, F.
    Durrbach, A.
    Vincenti, F.
    Harler, M. B.
    Duan, T.
    Rostaing, L.
    TRANSPLANT INTERNATIONAL, 2012, 25 : 24 - 24
  • [9] THREE YEAR OUTCOMES BY DONOR TYPE IN PHASE III STUDIES OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANTATION (BENEFIT AND BENEFIT-EXT)
    Florman, S.
    Becker, T.
    Bresnahan, B.
    Chevaile-Ramos, A.
    Carvalho, D.
    Muehlbacher, F.
    O'Connell, P.
    Duan, T.
    Agarwal, M.
    Larsen, C.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 51 - 51
  • [10] Outcomes at Five Years in Black/African-American Kidney Transplant Recipients from the Long-Term Extension of the Belatacept BENEFIT and BENEFIT-EXT Studies
    Florman, S.
    Rice, K.
    Chan, L.
    Zhang, R.
    Abouljoud, M.
    Steinberg, S.
    Pearson, T.
    Pupim, L.
    Vincenti, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 311 - 311